Quarterly report · Q1
9627.TEDINET S100P6MT
Period2022-05-01 → 2022-07-31
Filed2022-09-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.5bn | 2022-05-01 → 2022-07-31 | Cons. | Net sales |
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥75.0bn | 2021-05-01 → 2021-07-31 | Cons. | Net sales |
| Operating income | ¥2.8bn | 2022-05-01 → 2022-07-31 | Cons. | Operating income |
| Operating income | ¥2.6bn | 2021-05-01 → 2021-07-31 | Cons. | Operating income |
| Ordinary income | ¥3.1bn | 2022-05-01 → 2022-07-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2021-05-01 → 2021-07-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.0bn | 2022-05-01 → 2022-07-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.7bn | 2021-05-01 → 2021-07-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2022-05-01 → 2022-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2021-05-01 → 2021-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2022-05-01 → 2022-07-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2021-05-01 → 2021-07-31 | Cons. | Profit loss |
| Total assets | ¥228.4bn | at 2022-07-31 | Cons. | Assets |
| Total assets | ¥212.5bn | at 2022-04-30 | Cons. | Assets |
| Total assets | ¥203.6bn | at 2021-07-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥109.6bn | at 2022-07-31 | Cons. | Liabilities |
| Total liabilities | ¥93.5bn | at 2022-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥118.8bn | at 2022-07-31 | Cons. | Net assets |
| Net assets / equity | ¥119.0bn | at 2022-04-30 | Cons. | Net assets |
| Net assets / equity | ¥113.8bn | at 2021-07-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.9bn | at 2022-07-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.7bn | at 2022-04-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥48.53 | 2022-05-01 → 2022-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.1 | 2021-05-01 → 2021-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.0% | at 2022-07-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.9% | at 2021-07-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-05-01 → 2022-07-31 | ¥2.9bn |
| Otherother segments | revenue external | 2022-05-01 → 2022-07-31 | ¥2.9bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2022-07-31 | ¥18m |
| Otherother segments | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2022-07-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2022-07-31 | −¥18m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2022-07-31 | −¥1.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2022-07-31 | ¥72.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2022-07-31 | ¥72.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4.7bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2022-07-31 | ¥6.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2022-07-31 | ¥6.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥164m |
| —segment total | revenue | 2022-05-01 → 2022-07-31 | ¥81.5bn |
| —segment total | revenue external | 2022-05-01 → 2022-07-31 | ¥81.5bn |
| —segment total | revenue intersegment | 2022-05-01 → 2022-07-31 | ¥18m |
| —segment total | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4.9bn |
| Otherother segments | revenue | 2021-05-01 → 2021-07-31 | ¥3.1bn |
| Otherother segments | revenue external | 2021-05-01 → 2021-07-31 | ¥3.1bn |
| Otherother segments | revenue intersegment | 2021-05-01 → 2021-07-31 | ¥23m |
| Otherother segments | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥13m |
| Reconciling Itemsreconciling | revenue | 2021-05-01 → 2021-07-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-05-01 → 2021-07-31 | −¥23m |
| Reconciling Itemsreconciling | segment ordinary income | 2021-05-01 → 2021-07-31 | −¥1.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2021-05-01 → 2021-07-31 | ¥66.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2021-05-01 → 2021-07-31 | ¥66.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥4.9bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2021-05-01 → 2021-07-31 | ¥5.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2021-05-01 → 2021-07-31 | ¥5.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2021-05-01 → 2021-07-31 | −¥503m |
| —segment total | revenue | 2021-05-01 → 2021-07-31 | ¥75.0bn |
| —segment total | revenue external | 2021-05-01 → 2021-07-31 | ¥75.0bn |
| —segment total | revenue intersegment | 2021-05-01 → 2021-07-31 | ¥23m |
| —segment total | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥4.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 372
| Item | Context | Value | Unit |
|---|---|---|---|
| Accounts payable trade | Prior1YearInstant | 50756000000 | JPY |
| Accounts payable trade | CurrentQuarterInstant | 59462000000 | JPY |
| Short term loans payable | Prior1YearInstant | 2643000000 | JPY |
| Short term loans payable | CurrentQuarterInstant | 4167000000 | JPY |
| Income taxes payable | Prior1YearInstant | 4391000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 1361000000 | JPY |
| Deposits received | Prior1YearInstant | 15415000000 | JPY |
| Deposits received | CurrentQuarterInstant | 17343000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 2713000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 2362000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | 18000000 | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 12000000 | JPY |
| Contract liabilities | Prior1YearInstant | 544000000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 584000000 | JPY |
| Other cl | Prior1YearInstant | 5321000000 | JPY |
| Other cl | CurrentQuarterInstant | 6109000000 | JPY |
| Current liabilities | Prior1YearInstant | 81805000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 91402000000 | JPY |
| Long term loans payable | Prior1YearInstant | 5815000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 11218000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 3578000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 4260000000 | JPY |
| Other ncl | Prior1YearInstant | 2252000000 | JPY |
| Other ncl | CurrentQuarterInstant | 2738000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 11645000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 18217000000 | JPY |
| Liabilities | Prior1YearInstant | 93450000000 | JPY |
| Liabilities | CurrentQuarterInstant | 109620000000 | JPY |
| Capital stock | Prior1YearInstant | 21894000000 | JPY |
| Capital stock | CurrentQuarterInstant | 21894000000 | JPY |
| Capital surplus | Prior1YearInstant | 20500000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 20500000000 | JPY |
| Retained earnings | Prior1YearInstant | 78661000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 78433000000 | JPY |
| Treasury stock | Prior1YearInstant | -2018000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -2018000000 | JPY |
| Shareholders equity | Prior1YearInstant | 119038000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 118811000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -39000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -53000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -75000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -69000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -114000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -123000000 | JPY |
| Non controlling interests | Prior1YearInstant | 86000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 86000000 | JPY |
| Net assets | Prior1YearInstant | 119010000000 | JPY |
| Net assets | CurrentQuarterInstant | 118773000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 212461000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 228394000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |